This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GTH Genetron (GTH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Genetron Stock (NASDAQ:GTH) 30 days 90 days 365 days Advanced Chart Get Genetron alerts:Sign Up Key Stats Today's Range$4.02▼$4.0550-Day Range$3.85▼$4.0352-Week Range$2.08▼$4.05Volume412,603 shsAverage Volume51,662 shsMarket Capitalization$127.27 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China. Read More Receive GTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter. Email Address GTH Stock News HeadlinesGenetron Holdings Limited: Genetron Health Announces Completion of Going Private TransactionMarch 29, 2024 | finanznachrichten.deGenetron Health Announces Completion of Going Private TransactionMarch 28, 2024 | globenewswire.comNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system tracks breaking AI news and shows when to trade.📈 AI-backed. Beginner-friendly. Results proven.July 28 at 2:00 AM | Timothy Sykes (Ad)Genetron Holdings Limited: Genetron Health Announces Shareholders' Approval of Merger AgreementFebruary 21, 2024 | finanznachrichten.deGenetron Health Announces Shareholders’ Approval of Merger AgreementFebruary 21, 2024 | finance.yahoo.comGenetron Health Announces Shareholders' Approval of Merger AgreementFebruary 21, 2024 | globenewswire.comGenetron (NASDAQ: GTH)February 14, 2024 | fool.comGenetron Holdings Ltd. ADRFebruary 14, 2024 | wsj.comSee More Headlines GTH Stock Analysis - Frequently Asked Questions How were Genetron's earnings last quarter? Genetron Holdings Limited (NASDAQ:GTH) released its quarterly earnings data on Sunday, May, 23rd. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by $0.30. The firm had revenue of $14.05 million for the quarter. When did Genetron's stock split? Shares of Genetron reverse split on the morning of Thursday, October 26th 2023.The 1-3 reverse split was announced on Thursday, October 26th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 26th 2023. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. When did Genetron IPO? Genetron (GTH) raised $162 million in an IPO on Friday, June 19th 2020. The company issued 13,000,000 shares at $11.50-$13.50 per share. Credit Suisse and CICC served as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers. What other stocks do shareholders of Genetron own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genetron investors own include NVIDIA (NVDA), ServiceNow (NOW), Broadcom (AVGO), Adobe (ADBE), CrowdStrike (CRWD), Meta Platforms (META) and Arista Networks (ANET). Company Calendar Last Earnings5/23/2021Today7/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolNASDAQ:GTH CIK1782594 Webwww.genetronhealth.com Phone86-10-5090-7500FaxN/AEmployees993Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$94.34 million Price / Sales1.35 Cash FlowN/A Price / Cash FlowN/A Book Value$2.63 per share Price / Book1.53Miscellaneous Outstanding Shares31,620,000Free FloatN/AMarket Cap$127.27 million OptionableNot Optionable Beta0.51 Social Links 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NASDAQ:GTH) was last updated on 7/28/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredIs America’s Everything Bubble About to Burst?On July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTop 10 Green Zone Stocks to Buy NowOthers have paid $2,000 for access to stock picks like these—this weekend, you can get them free. Using a p...TradeSmith | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetron Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.